# Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

*PRI Rank #2 · Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026/rank-2*

| Field | Value |
| --- | --- |
| Rank | #2 |
| 18m citations | 136 |
| Journal | Journal of Clinical Oncology |
| Year | 2024 |
| DOI | 10.1200/jco.24.00826 |
| Corresponding authors | Ghayas C Issa |
| Institution | The University of Texas MD Anderson Cancer Center, United States |

**Ranking page:** [Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026](https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026)

**Paper link:** [10.1200/jco.24.00826](https://doi.org/10.1200/jco.24.00826)

## Topics

Revumenib · Menin inhibitor · KMT2A rearrangement · Relapsed/refractory acute leukemia · Menin-KMT2A interaction · AUGMENT-101 · Complete remission (CR) · CR with partial hematologic recovery · NPM1 mutation · differentiation syndrome · QT interval prolongation · Measurable residual disease (MRD) · cytochrome P450 inhibitor · targeted therapy · phase II trial

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```